Exogenous MOTS-c is dynamically transferred to the nucleus in a time-dependent manner, suggesting a direct nuclear role of MOTS-c in regulating nuclear gene expression, including its involvement in heat shock protein mediated responses and metabolism 25,51
The molecule was advanced into clinical development by the Croatian pharmaceutical company Pliva under the designations PL-10, PLD-116, and PL 14736 for inflammatory bowel disease research
Intermediate users commonly use 300-400 mcg daily, while advanced protocols may utilize 500 mcg daily or divided doses of 250 mcg twice per day
More information about the history of AOD-9604s development can be found here, and Dave Palumbo has a good 5-minute summary of the peptides effects: So how can we use AOD-9604 for weight loss in the human body
This combination acts as a signaling molecule, instructing cells to repair and regenerate
The quality is excellent, and the 300mg is perfect for my needs